scholarly journals Tissue levels of PIVKA-II and vitamin K in patients with hepatocellular carcinoma. Studies on the mechanism of the production of PIVKA-II.

Kanzo ◽  
1988 ◽  
Vol 29 (5) ◽  
pp. 699-700
Author(s):  
Masataka OKUNO ◽  
Yasushi FUKUTOMI ◽  
Makoto SHIMAZAKI ◽  
Tetsuya YAMADA ◽  
Nobuo MURAKAMI ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Vitamin K ◽  
Tissue Levels

scholarly journals Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study

2021 ◽  
Vol 10 (3) ◽  
pp. 914-922
Author(s):  
Yoshimichi Haruna ◽  
Takayuki Yakushijin ◽  
Seiichi Kawamoto
Keyword(s):  
Hepatocellular Carcinoma ◽  
Phase Ii ◽  
Vitamin K ◽  
Randomized Study ◽  
Efficacy And Safety

scholarly journals Tissue Levels of Stefin A and Stefin B in Hepatocellular Carcinoma

2016 ◽  
Vol 299 (4) ◽  
pp. 428-438 ◽  
Author(s):  
Yang-Yuan Lin ◽  
Zhi-Wei Chen ◽  
Zhi-Ping Lin ◽  
Li-Bin Lin ◽  
Xue-Ming Yang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Tissue Levels ◽  
Stefin A

Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma

Tumor Biology ◽  
2016 ◽  
Vol 37 (12) ◽  
pp. 15447-15456 ◽  
Author(s):  
Hao Xing ◽  
Cunling Yan ◽  
Liming Cheng ◽  
Nianyue Wang ◽  
Shuyang Dai ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Clinical Application ◽  
Vitamin K ◽  
Vitamin K Antagonist

scholarly journals Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein

Cancer ◽  
1994 ◽  
Vol 73 (10) ◽  
pp. 2464-2471 ◽  
Author(s):  
Taketoshi Suehiro ◽  
Keizo Sugimachi ◽  
Takashi Matsumata ◽  
Hidetoshi Itasaka ◽  
Akinobu Taketomi ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Prognostic Marker ◽  
Vitamin K ◽  
Alpha Fetoprotein
Sign in / Sign up

Export Citation Format

Share Document